✦ LIBER ✦

Characterization of CHEK2 mutations in prostate cancer

✍ Scribed by Xianglin Wu; Xiangyang Dong; Wanguo Liu; Junjie Chen

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 218 KB
Volume: 27
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.20321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHEK2 mutations and HNPCC-related colore

CHEK2 mutations and HNPCC-related colorectal cancer

✍ Janina Suchy; Cezary Cybulski; Dominika Wokołorczyk; Oleg Oszurek; Bohdan Górski 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB

## Abstract Recently, the 1100delC variant of cell cycle checkpoint kinase 2 (CHEK2) has been reported to confer a colorectal cancer risk in hereditary non‐polyposis‐colorectal cancer (HNPCC) and HNPCC‐related families in the Netherlands. To investigate whether CHEK2 mutations confer increased canc

Colorectal cancer and the CHEK2 1100delC

Colorectal cancer and the CHEK2 1100delC mutation

✍ Mirjam M. de Jong; Ilja M. Nolte; Gerard J. te Meerman; Winette T. A. van der Gr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract The __CHEK2__ 1100delC mutation was recently identified as a low‐penetrance breast cancer susceptibility allele. The mutation occurred more frequently in families with clustering of breast and colorectal cancers (CRCs) than in families with clustering of breast cancer only. Hence, the 1

Association of two mutations in the CHEK

Association of two mutations in the CHEK2 gene with breast cancer

✍ Natalia Bogdanova; Natalia Enβen-Dubrowinskaja; Sergei Feshchenko; Gennady I. La 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 148 KB 👁 2 views

## Abstract The 1100delC mutation of the cell cycle checkpoint kinase 2 (__CHEK2__) gene confers an increased risk for breast cancer, but the clinical impact of other __CHEK2__ gene variants remains unclear. We determined the frequency of two functionally relevant __CHEK2__ gene mutations, I157T an

Unique substitution of CHEK2 and TP53 mu

Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines

✍ Li Zheng; Fengwei Wang; Chiping Qian; Roxann M. Neumann; John C. Cheville; Donal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

## Communicated by Marc S. Greenblatt Genetic defects in CHEK2 and TP53 have been implicated in prostate cancer development. However, the interaction of these two genes in prostate cancer tumorigenesis has not been investigated. We previously described 11 CHEK2 mutations in a group of 84 primary p

Prevalent mutations in prostate cancer

✍ Jin-Tang Dong 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Quantitative and structural genetic alterations cause the development and progression of prostate cancer. A number of genes have been implicated in prostate cancer by genetic alterations and functional consequences of the genetic alterations. These include the __ELAC2__ (__HPC2__), __MS

BRCA2 mutation in a family with heredita

BRCA2 mutation in a family with hereditary prostate cancer

✍ Henrik Grönberg; Anna-Karin Åhman; Monica Emanuelsson; Anders Bergh; Jan-Erik Da 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views